The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases

[1]  R. Lifton,et al.  Autotransplantation for relapsed or refractory non-Hodgkin’s lymphoma (NHL): long-term follow-up and analysis of prognostic factors , 1997, Bone Marrow Transplantation.

[2]  G. Salles,et al.  Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93 , 1997 .

[3]  R. Tsang,et al.  The Role of Intensive Therapy and Autologous Blood and Marrow Transplantation for Chemotherapy‐Sensitive Relapsed and Primary Refractory Non‐Hodgkin’s Lymphoma: Identification of Major Prognostic Groups , 1996, British journal of haematology.

[4]  A. Hagenbeek,et al.  Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. , 1995, The New England journal of medicine.

[5]  K. van Besien,et al.  High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity. , 1995, Bone marrow transplantation.

[6]  B. Coiffier.  Fourteen years of high-dose CHOP (ACVB regimen): preliminary conclusions about the treatment of aggressive-lymphoma patients. Hamilton Fairley Award Lecture, European Society for Medical Oncology Meeting, Lisbon, November 21, 1994. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  P. Cony-Makhoul,et al.  Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. , 1995, Blood.

[8]  E. Abella,et al.  Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. , 1994, Blood.

[9]  J. Garcia-conde,et al.  Prognostic factors in patients who received autologous bone marrow transplantation for non-Hodgkin's lymphoma. Report of 104 patients from the Spanish Cooperative Group GEL/TAMO. , 1994, Bone marrow transplantation.

[10]  S. Tucker,et al.  ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  G. Salles,et al.  Chemotherapy of non-Hodgkin's aggressive lymphomas. , 1994, Seminars in hematology.

[12]  J. Armitage,et al.  High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  W. Wilson,et al.  EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Strawderman,et al.  Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  T M Grogan,et al.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[16]  C. Gisselbrecht,et al.  Secondary acute myeloid leukemia after autologous bone marrow transplantation for malignant lymphomas. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  B. Coiffier,et al.  Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  C. Gisselbrecht,et al.  Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  R. Motzer,et al.  Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  P. Morel,et al.  VIM3‐ARA C: An effective salvage regimen in refractory or recurrent aggressive non hodgkin's lymphoma. A report on 18 cases , 2006, Hematological oncology.

[21]  B. Yeap,et al.  Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  K. Sullivan,et al.  Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  H. Earl,et al.  Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  S. Jagannath,et al.  Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). , 1988, Blood.

[25]  H. Deeg,et al.  Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Armitage,et al.  High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. , 1987, The New England journal of medicine.

[27]  G. Fillet,et al.  [Treatment of non-Hodgkin's lymphoma]. , 1987, Revue medicale de Liege.

[28]  W. Velasquez,et al.  Results of MIME salvage regimen for recurrent or refractory lymphoma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .

[30]  D.,et al.  Regression Models and Life-Tables , 2022 .